Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Ultrasound Treatment Proves Helpful to Prostate Cancer Sufferers

By HospiMedica staff writers
Posted on 25 Dec 2007
Prostate cancer experts report that high intensity focused ultrasound (HIFU) is an effective treatment option for men with prostate cancer.

Specialists from the University of Regensburg (Regensburg, Germany), Edouard Herriot Hospital (Lyon, France), and Klinikum München-Harlaching (München, Germany) studied the results of 140 people with prostate cancer over an eight-year-period and published their findings in the online edition of the December 2007 issue of the European Journal of Urology.

The researchers found that HIFU treatment resulted in negative biopsies in nearly nine out of 10 (86%) patients, and after five years, men's prostate-specific antigen (PSA) levels were low and stable in eight out 10 (77%) cases, indicating a high treatment success rate. More...
The researchers tracked all the patients for at least five years and concluded that HIFU is effective in treating prostate cancer where the cancer has not metastasized outside the prostate, and that HIFU is a valid alternative to radiotherapy.

HIFU is a minimally invasive treatment for localized prostate cancer in which precisely targeted ultrasound waves are focused within the prostate and instantly destroy cancerous cells. The treatment lasts one to three hours and, unlike surgery or radiation therapy, can be repeated if necessary. The researchers reported that these results show that HIFU is not only an effective treatment option for prostate cancer, but that the side-effects such as incontinence and impotence are milder than those of other treatments.

Study co-author and leading prostate cancer specialist Dr. Andreas Blana, from the department of urology, University of Regensburg, said, "This study is the first of its kind in examining the long-term results of HIFU treatment. This innovative and revolutionary treatment clearly has the capacity to help men with prostate cancer all around the world. Indeed, I would say it is an ideal treatment option for men with localized prostate cancer and it should be part of a doctor's armory when treating the disease.”


Related Links:
University of Regensburg

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Gold Member
Electrode Solution and Skin Prep
Signaspray
Exam Table
PF400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.